Drug evaluation: tagatose in the treatment of type 2 diabetes and obesity |
| |
| Authors: | Moore Mary Courtney |
| |
| Affiliation: | Vanderbilt University School of Medicine, Department of Molecular Physiology and Biophysics, 702 Light Hall, Nashville, TN 37232, USA. genie.moore@vanderbilt.edu |
| |
| Abstract: | Spherix Inc (formerly Biospherics) is developing tagatose, an orally active lactose derivative for the potential treatment of obesity and type 2 diabetes. The compound is also under investigation for the potential treatment of anemia, hemophilia and medical problems related to infertility, birth weight and excessive maternal food intake. Phase I and II clinical trials have been completed. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
